PDB Short entry for 3ET2 HEADER TRANSCRIPTION 06-OCT-08 3ET2 TITLE STRUCTURE OF PPARDELTA WITH 3-[5-METHOXY-1-(4-METHOXY- TITLE 2 BENZENESULFONYL)-1H-INDOL-3-YL]-PROPIONIC ACID COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN; COMPND 5 SYNONYM: PPAR-DELTA, PPAR- BETA, NUCLEAR RECEPTOR SUBFAMILY 1 GROUP C COMPND 6 MEMBER 2, NUCLEAR HORMONE RECEPTOR 1, NUC1, NUCI; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PPARD, NR1C2, PPARB; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)RIL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET-28 KEYWDS PPAR, PPARD, PPARDELTA, DRUG DISCOVERY, DIABETES, ADIPONECTIN, KEYWDS 2 METABOLIC DISEASE, FRAGMENT-BASED DRUG DISCOVERY, SCAFFOLD-BASED KEYWDS 3 DRUG DISCOVERY, ACTIVATOR, ALTERNATIVE SPLICING, DNA-BINDING, METAL- KEYWDS 4 BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, KEYWDS 5 ZINC, ZINC-FINGER, K.ZHANG, WED OCT 1 17:27:09 2008 ON NOD EXPDTA X-RAY DIFFRACTION AUTHOR K.Y.J.ZHANG,W.WANG REVDAT 3 06-SEP-23 3ET2 1 REMARK SEQADV REVDAT 2 11-OCT-17 3ET2 1 REMARK REVDAT 1 17-FEB-09 3ET2 0 JRNL AUTH D.R.ARTIS,J.J.LIN,C.ZHANG,W.WANG,U.MEHRA,M.PERREAULT,D.ERBE, JRNL AUTH 2 H.I.KRUPKA,B.P.ENGLAND,J.ARNOLD,A.N.PLOTNIKOV,A.MARIMUTHU, JRNL AUTH 3 H.NGUYEN,S.WILL,M.SIGNAEVSKY,J.KRAL,J.CANTWELL, JRNL AUTH 4 C.SETTACHATGULL,D.S.YAN,D.FONG,A.OH,S.SHI,P.WOMACK,B.POWELL, JRNL AUTH 5 G.HABETS,B.L.WEST,K.Y.ZHANG,M.V.MILBURN,G.P.VLASUK, JRNL AUTH 6 K.P.HIRTH,K.NOLOP,G.BOLLAG,P.N.IBRAHIM,J.F.TOBIN JRNL TITL SCAFFOLD-BASED DISCOVERY OF INDEGLITAZAR, A PPAR PAN-ACTIVE JRNL TITL 2 ANTI-DIABETIC AGENT JRNL REF PROC.NATL.ACAD.SCI.USA V. 106 262 2009 JRNL REFN ISSN 0027-8424 JRNL PMID 19116277 JRNL DOI 10.1073/PNAS.0811325106 REMARK 2 REMARK 2 RESOLUTION. 2.24 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.24 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.99 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 33474 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.188 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.050 REMARK 3 FREE R VALUE TEST SET COUNT : 1689 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 38.9982 - 5.1248 0.93 2561 139 0.1878 0.2426 REMARK 3 2 5.1248 - 4.0691 0.98 2637 156 0.1364 0.2003 REMARK 3 3 4.0691 - 3.5551 0.98 2624 147 0.1325 0.1660 REMARK 3 4 3.5551 - 3.2303 0.99 2631 159 0.1543 0.2151 REMARK 3 5 3.2303 - 2.9988 0.99 2655 144 0.1774 0.2630 REMARK 3 6 2.9988 - 2.8221 1.00 2665 140 0.1934 0.2519 REMARK 3 7 2.8221 - 2.6808 1.00 2670 150 0.1946 0.2943 REMARK 3 8 2.6808 - 2.5641 1.00 2686 120 0.2006 0.2764 REMARK 3 9 2.5641 - 2.4654 0.99 2651 124 0.2083 0.2674 REMARK 3 10 2.4654 - 2.3803 1.00 2685 146 0.2235 0.3034 REMARK 3 11 2.3803 - 2.3059 0.99 2640 127 0.2298 0.2999 REMARK 3 12 2.3059 - 2.2400 1.00 2680 137 0.2573 0.3092 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.36 REMARK 3 B_SOL : 51.52 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.330 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.130 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.77780 REMARK 3 B22 (A**2) : 7.10720 REMARK 3 B33 (A**2) : -8.81980 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 2.33400 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.000 4451 REMARK 3 ANGLE : 1.080 6016 REMARK 3 CHIRALITY : 0.060 678 REMARK 3 PLANARITY : 0.000 754 REMARK 3 DIHEDRAL : 16.820 1660 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN A REMARK 3 ORIGIN FOR THE GROUP (A): 27.5926 8.6272 66.2076 REMARK 3 T TENSOR REMARK 3 T11: 0.0512 T22: 0.0580 REMARK 3 T33: 0.0826 T12: -0.0093 REMARK 3 T13: -0.0108 T23: -0.0082 REMARK 3 L TENSOR REMARK 3 L11: 1.1063 L22: 0.7423 REMARK 3 L33: 0.7903 L12: -0.0732 REMARK 3 L13: -0.4789 L23: 0.3316 REMARK 3 S TENSOR REMARK 3 S11: -0.0006 S12: 0.0636 S13: -0.0573 REMARK 3 S21: 0.0714 S22: -0.0061 S23: 0.0493 REMARK 3 S31: 0.0129 S32: -0.0489 S33: 0.0592 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN B REMARK 3 ORIGIN FOR THE GROUP (A): 25.1630 47.0192 77.3455 REMARK 3 T TENSOR REMARK 3 T11: 0.1928 T22: 0.1499 REMARK 3 T33: 0.1514 T12: 0.0040 REMARK 3 T13: 0.0076 T23: 0.0009 REMARK 3 L TENSOR REMARK 3 L11: 0.9719 L22: 0.6575 REMARK 3 L33: 1.0044 L12: -0.2788 REMARK 3 L13: 0.1197 L23: 0.2664 REMARK 3 S TENSOR REMARK 3 S11: 0.0361 S12: -0.0436 S13: -0.0300 REMARK 3 S21: 0.0122 S22: 0.0364 S23: -0.0155 REMARK 3 S31: -0.1224 S32: -0.0893 S33: -0.0000 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3ET2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-OCT-08. REMARK 100 THE DEPOSITION ID IS D_1000049731. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-MAY-06 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.3.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33526 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.240 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.09800 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.24 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.30 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.48900 REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CCP4 REMARK 200 STARTING MODEL: PDB ENTRY 1GWX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.67 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.71 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: THE PURIFIED PPARD LBD PROTEIN WAS REMARK 280 DILUTED TO 10MG/ML AND 1MM OF INDEGLITAZAR WAS ADDED TO THE REMARK 280 DILUTED PROTEIN PRIOR TO CRYSTALLIZATION BY MIXING EQUAL VOLUMES REMARK 280 OF PROTEIN/COMPOUND SAMPLE WITH RESERVOIR SOLUTION CONTAINING 16% REMARK 280 PEG 3350, 0.1 M TRIS BUFFER AT PH 7.5, 0.2 M MAGNESIUM CHLORIDE, REMARK 280 AND 1% N-BUTANOL, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 47.17650 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 155 REMARK 465 LYS A 156 REMARK 465 LYS A 157 REMARK 465 GLY A 158 REMARK 465 HIS A 159 REMARK 465 HIS A 160 REMARK 465 HIS A 161 REMARK 465 HIS A 162 REMARK 465 HIS A 163 REMARK 465 HIS A 164 REMARK 465 GLY A 165 REMARK 465 SER A 166 REMARK 465 GLN A 167 REMARK 465 TYR A 168 REMARK 465 ASN A 169 REMARK 465 PRO A 170 REMARK 465 GLN A 171 REMARK 465 LYS A 229 REMARK 465 GLN A 230 REMARK 465 LEU A 231 REMARK 465 TYR A 441 REMARK 465 MET B 155 REMARK 465 LYS B 156 REMARK 465 LYS B 157 REMARK 465 GLY B 158 REMARK 465 HIS B 159 REMARK 465 HIS B 160 REMARK 465 HIS B 161 REMARK 465 HIS B 162 REMARK 465 HIS B 163 REMARK 465 HIS B 164 REMARK 465 GLY B 165 REMARK 465 SER B 166 REMARK 465 GLN B 167 REMARK 465 TYR B 168 REMARK 465 ASN B 169 REMARK 465 PRO B 170 REMARK 465 GLN B 171 REMARK 465 VAL B 172 REMARK 465 GLN B 230 REMARK 465 LEU B 231 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O LYS B 204 O HOH B 601 2.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 205 -33.60 110.59 REMARK 500 HIS A 207 21.92 47.35 REMARK 500 VAL A 227 -45.99 -136.85 REMARK 500 ASN A 233 44.57 -161.13 REMARK 500 LYS A 239 -42.77 -131.99 REMARK 500 GLU A 240 160.88 170.78 REMARK 500 MET A 365 -61.25 -92.36 REMARK 500 LYS B 204 -152.48 -98.50 REMARK 500 ALA B 205 -148.57 42.51 REMARK 500 SER B 206 -96.43 -32.34 REMARK 500 HIS B 207 -174.78 166.74 REMARK 500 THR B 208 104.53 86.03 REMARK 500 LEU B 226 -45.25 68.31 REMARK 500 TRP B 228 -120.33 55.30 REMARK 500 LYS B 239 -49.81 -137.09 REMARK 500 PRO B 268 -80.65 -16.61 REMARK 500 ALA B 306 71.76 51.36 REMARK 500 ASN B 307 44.41 25.08 REMARK 500 ASN B 366 70.69 -102.83 REMARK 500 GLU B 424 58.16 -96.13 REMARK 500 ASP B 439 -2.43 79.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ET1 A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1BO A 3 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1BO A 4 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1BO A 6 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ET1 B 2 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3ET0 RELATED DB: PDB REMARK 900 STRUCTURE OF PPARGAMMA WITH 3-(5-METHOXY-1H-INDOL-3-YL)-PROPIONIC REMARK 900 ACID REMARK 900 RELATED ID: 3ET1 RELATED DB: PDB REMARK 900 STRUCTURE OF PPARALPHA WITH 3-[5-METHOXY-1-(4-METHOXY- REMARK 900 BENZENESULFONYL)-1H-INDOL-3-YL]-PROPIONIC ACID REMARK 900 RELATED ID: 3ET3 RELATED DB: PDB REMARK 900 STRUCTURE OF PPARGAMMA WITH 3-[5-METHOXY-1-(4-METHOXY- REMARK 900 BENZENESULFONYL)-1H-INDOL-3-YL]-PROPIONIC ACID DBREF 3ET2 A 165 441 UNP Q03181 PPARD_HUMAN 165 441 DBREF 3ET2 B 165 441 UNP Q03181 PPARD_HUMAN 165 441 SEQADV 3ET2 MET A 155 UNP Q03181 EXPRESSION TAG SEQADV 3ET2 LYS A 156 UNP Q03181 EXPRESSION TAG SEQADV 3ET2 LYS A 157 UNP Q03181 EXPRESSION TAG SEQADV 3ET2 GLY A 158 UNP Q03181 EXPRESSION TAG SEQADV 3ET2 HIS A 159 UNP Q03181 EXPRESSION TAG SEQADV 3ET2 HIS A 160 UNP Q03181 EXPRESSION TAG SEQADV 3ET2 HIS A 161 UNP Q03181 EXPRESSION TAG SEQADV 3ET2 HIS A 162 UNP Q03181 EXPRESSION TAG SEQADV 3ET2 HIS A 163 UNP Q03181 EXPRESSION TAG SEQADV 3ET2 HIS A 164 UNP Q03181 EXPRESSION TAG SEQADV 3ET2 MET B 155 UNP Q03181 EXPRESSION TAG SEQADV 3ET2 LYS B 156 UNP Q03181 EXPRESSION TAG SEQADV 3ET2 LYS B 157 UNP Q03181 EXPRESSION TAG SEQADV 3ET2 GLY B 158 UNP Q03181 EXPRESSION TAG SEQADV 3ET2 HIS B 159 UNP Q03181 EXPRESSION TAG SEQADV 3ET2 HIS B 160 UNP Q03181 EXPRESSION TAG SEQADV 3ET2 HIS B 161 UNP Q03181 EXPRESSION TAG SEQADV 3ET2 HIS B 162 UNP Q03181 EXPRESSION TAG SEQADV 3ET2 HIS B 163 UNP Q03181 EXPRESSION TAG SEQADV 3ET2 HIS B 164 UNP Q03181 EXPRESSION TAG SEQRES 1 A 287 MET LYS LYS GLY HIS HIS HIS HIS HIS HIS GLY SER GLN SEQRES 2 A 287 TYR ASN PRO GLN VAL ALA ASP LEU LYS ALA PHE SER LYS SEQRES 3 A 287 HIS ILE TYR ASN ALA TYR LEU LYS ASN PHE ASN MET THR SEQRES 4 A 287 LYS LYS LYS ALA ARG SER ILE LEU THR GLY LYS ALA SER SEQRES 5 A 287 HIS THR ALA PRO PHE VAL ILE HIS ASP ILE GLU THR LEU SEQRES 6 A 287 TRP GLN ALA GLU LYS GLY LEU VAL TRP LYS GLN LEU VAL SEQRES 7 A 287 ASN GLY LEU PRO PRO TYR LYS GLU ILE SER VAL HIS VAL SEQRES 8 A 287 PHE TYR ARG CYS GLN CYS THR THR VAL GLU THR VAL ARG SEQRES 9 A 287 GLU LEU THR GLU PHE ALA LYS SER ILE PRO SER PHE SER SEQRES 10 A 287 SER LEU PHE LEU ASN ASP GLN VAL THR LEU LEU LYS TYR SEQRES 11 A 287 GLY VAL HIS GLU ALA ILE PHE ALA MET LEU ALA SER ILE SEQRES 12 A 287 VAL ASN LYS ASP GLY LEU LEU VAL ALA ASN GLY SER GLY SEQRES 13 A 287 PHE VAL THR ARG GLU PHE LEU ARG SER LEU ARG LYS PRO SEQRES 14 A 287 PHE SER ASP ILE ILE GLU PRO LYS PHE GLU PHE ALA VAL SEQRES 15 A 287 LYS PHE ASN ALA LEU GLU LEU ASP ASP SER ASP LEU ALA SEQRES 16 A 287 LEU PHE ILE ALA ALA ILE ILE LEU CYS GLY ASP ARG PRO SEQRES 17 A 287 GLY LEU MET ASN VAL PRO ARG VAL GLU ALA ILE GLN ASP SEQRES 18 A 287 THR ILE LEU ARG ALA LEU GLU PHE HIS LEU GLN ALA ASN SEQRES 19 A 287 HIS PRO ASP ALA GLN TYR LEU PHE PRO LYS LEU LEU GLN SEQRES 20 A 287 LYS MET ALA ASP LEU ARG GLN LEU VAL THR GLU HIS ALA SEQRES 21 A 287 GLN MET MET GLN ARG ILE LYS LYS THR GLU THR GLU THR SEQRES 22 A 287 SER LEU HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP MET SEQRES 23 A 287 TYR SEQRES 1 B 287 MET LYS LYS GLY HIS HIS HIS HIS HIS HIS GLY SER GLN SEQRES 2 B 287 TYR ASN PRO GLN VAL ALA ASP LEU LYS ALA PHE SER LYS SEQRES 3 B 287 HIS ILE TYR ASN ALA TYR LEU LYS ASN PHE ASN MET THR SEQRES 4 B 287 LYS LYS LYS ALA ARG SER ILE LEU THR GLY LYS ALA SER SEQRES 5 B 287 HIS THR ALA PRO PHE VAL ILE HIS ASP ILE GLU THR LEU SEQRES 6 B 287 TRP GLN ALA GLU LYS GLY LEU VAL TRP LYS GLN LEU VAL SEQRES 7 B 287 ASN GLY LEU PRO PRO TYR LYS GLU ILE SER VAL HIS VAL SEQRES 8 B 287 PHE TYR ARG CYS GLN CYS THR THR VAL GLU THR VAL ARG SEQRES 9 B 287 GLU LEU THR GLU PHE ALA LYS SER ILE PRO SER PHE SER SEQRES 10 B 287 SER LEU PHE LEU ASN ASP GLN VAL THR LEU LEU LYS TYR SEQRES 11 B 287 GLY VAL HIS GLU ALA ILE PHE ALA MET LEU ALA SER ILE SEQRES 12 B 287 VAL ASN LYS ASP GLY LEU LEU VAL ALA ASN GLY SER GLY SEQRES 13 B 287 PHE VAL THR ARG GLU PHE LEU ARG SER LEU ARG LYS PRO SEQRES 14 B 287 PHE SER ASP ILE ILE GLU PRO LYS PHE GLU PHE ALA VAL SEQRES 15 B 287 LYS PHE ASN ALA LEU GLU LEU ASP ASP SER ASP LEU ALA SEQRES 16 B 287 LEU PHE ILE ALA ALA ILE ILE LEU CYS GLY ASP ARG PRO SEQRES 17 B 287 GLY LEU MET ASN VAL PRO ARG VAL GLU ALA ILE GLN ASP SEQRES 18 B 287 THR ILE LEU ARG ALA LEU GLU PHE HIS LEU GLN ALA ASN SEQRES 19 B 287 HIS PRO ASP ALA GLN TYR LEU PHE PRO LYS LEU LEU GLN SEQRES 20 B 287 LYS MET ALA ASP LEU ARG GLN LEU VAL THR GLU HIS ALA SEQRES 21 B 287 GLN MET MET GLN ARG ILE LYS LYS THR GLU THR GLU THR SEQRES 22 B 287 SER LEU HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP MET SEQRES 23 B 287 TYR HET ET1 A 1 27 HET 1BO A 3 5 HET 1BO A 4 5 HET 1BO A 6 5 HET ET1 B 2 27 HETNAM ET1 3-{5-METHOXY-1-[(4-METHOXYPHENYL)SULFONYL]-1H-INDOL-3- HETNAM 2 ET1 YL}PROPANOIC ACID HETNAM 1BO 1-BUTANOL HETSYN 1BO BUTAN-1-OL FORMUL 3 ET1 2(C19 H19 N O6 S) FORMUL 4 1BO 3(C4 H10 O) FORMUL 8 HOH *372(H2 O) HELIX 1 1 ASP A 174 PHE A 190 1 17 HELIX 2 2 THR A 193 THR A 202 1 10 HELIX 3 3 ASP A 215 LYS A 224 1 10 HELIX 4 4 GLU A 240 SER A 266 1 27 HELIX 5 5 ILE A 267 LEU A 273 1 7 HELIX 6 6 PHE A 274 ALA A 295 1 22 HELIX 7 7 ARG A 314 SER A 319 1 6 HELIX 8 8 PRO A 323 ILE A 327 5 5 HELIX 9 9 ILE A 328 ALA A 340 1 13 HELIX 10 10 ASP A 344 LEU A 357 1 14 HELIX 11 11 ASN A 366 HIS A 389 1 24 HELIX 12 12 TYR A 394 GLU A 424 1 31 HELIX 13 13 HIS A 430 LYS A 438 1 9 HELIX 14 14 ASP B 174 LYS B 188 1 15 HELIX 15 15 THR B 193 GLY B 203 1 11 HELIX 16 16 ASP B 215 LYS B 224 1 10 HELIX 17 17 GLU B 240 SER B 266 1 27 HELIX 18 18 SER B 269 LEU B 273 5 5 HELIX 19 19 PHE B 274 ALA B 295 1 22 HELIX 20 20 ALA B 306 GLY B 308 5 3 HELIX 21 21 ARG B 314 SER B 319 1 6 HELIX 22 22 ILE B 328 ALA B 340 1 13 HELIX 23 23 ASP B 344 LEU B 357 1 14 HELIX 24 24 ASN B 366 HIS B 389 1 24 HELIX 25 25 TYR B 394 GLU B 424 1 31 HELIX 26 26 HIS B 430 LYS B 438 1 9 SHEET 1 A 4 PHE A 211 ILE A 213 0 SHEET 2 A 4 GLY A 310 THR A 313 1 O PHE A 311 N ILE A 213 SHEET 3 A 4 GLY A 302 VAL A 305 -1 N LEU A 303 O VAL A 312 SHEET 4 A 4 VAL A 298 ASN A 299 -1 N ASN A 299 O GLY A 302 SHEET 1 B 4 PHE B 211 ILE B 213 0 SHEET 2 B 4 GLY B 310 THR B 313 1 O PHE B 311 N ILE B 213 SHEET 3 B 4 GLY B 302 VAL B 305 -1 N LEU B 303 O VAL B 312 SHEET 4 B 4 VAL B 298 ASN B 299 -1 N ASN B 299 O GLY B 302 CISPEP 1 LYS A 322 PRO A 323 0 8.88 CISPEP 2 LYS B 322 PRO B 323 0 4.05 SITE 1 AC1 14 PHE A 246 CYS A 249 THR A 253 HIS A 287 SITE 2 AC1 14 PHE A 291 PHE A 324 ILE A 327 LYS A 331 SITE 3 AC1 14 HIS A 413 MET A 417 LEU A 433 TYR A 437 SITE 4 AC1 14 HOH A 444 HOH A 534 SITE 1 AC2 4 THR A 261 LEU A 282 PHE B 274 LEU B 275 SITE 1 AC3 2 LEU A 275 THR B 261 SITE 1 AC4 3 LEU A 219 TRP A 220 ILE A 241 SITE 1 AC5 19 PHE B 246 CYS B 249 GLN B 250 THR B 252 SITE 2 AC5 19 THR B 253 HIS B 287 ILE B 290 PHE B 291 SITE 3 AC5 19 LEU B 294 PHE B 324 ILE B 327 ILE B 328 SITE 4 AC5 19 LYS B 331 HIS B 413 MET B 417 LEU B 433 SITE 5 AC5 19 TYR B 437 HOH B 461 HOH B 576 CRYST1 39.402 94.353 97.183 90.00 98.27 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025379 0.000000 0.003689 0.00000 SCALE2 0.000000 0.010598 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010398 0.00000